Critical appraisal of recent translational chronopharmacology and chronotherapeutic reviews, meta-analyses, and pragmatic patient trials discloses significant deficiencies of design and conduct and suspect findings

References

• Abuelazm M, Saleh O, Albarakat MM, Katamesh B, Abdalshafy H, Mahmoud A, Abdelazeem B. 2023. The effect of bedtime versus morning dosing of antihypertensive drugs on the cardiovascular outcomes: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 41:1595–1605. doi:10.1097/HJH.0000000000003508.
   PubMedGoogle Scholar
• Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. 2007. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension. 49:1235–1241. doi:10.1161/HYPERTENSIONAHA.107.087262.
   PubMed Web of Science ®Google Scholar
• Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourcière Y, et al. 2003. Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial. JAMA. 289:2073–2082. doi:10.1001/jama.289.16.2073.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, et al. 2007. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 370:1219–1229. doi:10.1016/S0140-6736(07)61538-4.
   PubMed Web of Science ®Google Scholar
• Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, Salgado JL, et al. 2020. The Hygia project and Hygia chronotherapy trial: insights of we clinical investigators on the impact of the embedded continuing medical education on primary-care practice and improved patient cardiovascular health. Chronobiol Int. 5:759–766. doi:10.1080/07420528.2020.1771357.
   Google Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E. 2005. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 46:156–161. doi:10.1161/01.HYP.0000170138.56903.7a.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. 2008. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 51:55–61. doi:10.1161/HYPERTENSIONAHA.107.100727.
   PubMed Web of Science ®Google Scholar
• Garrison SR, Kolber MR, Allan GM, Bakal J, Green L, Singer A, Trueman DR, McAlister FA, Padwal RS, Hill MD, et al. 2022. Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): Protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial. BMJ Open. 12:e059711. doi:10.1136/bmjopen-2021-059711.
   PubMedGoogle Scholar
• Hermida RC. 2016. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: rationale and design of the Hygia project. Chronobiol Int. 33:906–936. doi:10.1080/07420528.2016.1181078.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2013a. Ambulatory blood pressure monitoring: importance of sampling rate and duration—48 versus 24 hours—on the accurate assessment of cardiovascular risk. Chronobiol Int. 30:55–67. doi:10.3109/07420528.2012.701457.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 27:1629–1651. doi:10.3109/07420528.2010.510230.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–1173. doi:10.1016/j.jacc.2011.04.043.
   PubMed Web of Science ®Google Scholar
• Hermida-Ayala RG, Mojón A, Fernández JR, Smolensky MH, Hermida RC. 2022. Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: systematic review and meta-analysis of published human trials. Chronobiol Int. 39:493–512. doi:10.1080/07420528.2021.2005084.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Smolensky MH, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, et al. 2021a. Cardiovascular disease risk stratification by the Framingham score is markedly improved by ambulatory compared to office blood pressure. Rev Esp Cardiol. 74:953–961.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al. 2020a. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia chronotherapy trial. Eur Heart J. 41:4565–4576. doi:10.1093/eurheartj/ehz754.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39:4159–4171. doi:10.1093/eurheartj/ehy475.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Mojón A, Smolensky MH, Fernández JR. 2021b. Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations. Chronobiol Int. 38:1460–1476. doi:10.1080/07420528.2021.1931280.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2020b. Chronopharmacology of hypertension medications: Impact of ingestion-time on pharmacokinetics and pharmacodynamics. Exp Opin Drug Metab Toxicol. 16:1159–1173. doi:10.1080/17425255.2020.182568.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2021c. Ingestion-time differences in the pharmacodynamics of hypertension medications: systematic review of human chronopharmacology trials. Adv Drug Deliv Rev. 170:200–213. doi:10.1016/j.addr.2021.01.013.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Hermida-Ayala RG, Crespo JJ, Ríos MT, Domínguez-Sardiña M, Otero A, Smolensky MH. 2023. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: a review of the published literature. Chronobiol Int. 40:63–82. doi:10.1080/07420528.2021.1939367.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Otero A, Crespo JJ, Domínguez-Sardiña M, Ríos MT, Smolensky MH. 2020c. Ambulatory blood pressure monitoring-based definition of true arterial hypertension. Minerva Med. 111:573–588. doi:10.23736/S0026-4806.20.06834-2.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Hermida-Ayala RG, Smolensky MH, Fernández JR. 2021d. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: systematic review and meta-analysis of published human trials. Sleep Med Rev. 59:101454. doi:10.1016/j.smrv.2021.101454.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Smolensky MH, Fernández JR. 2021e. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: controversies in hypertension—pro side of the argument. Hypertension. 78:879–893. doi:10.1161/HYPERTENSIONAHA.120.16500.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013b. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the international society for chronobiology (ISC), American association of medical chronobiology and chronotherapeutics (AAMCC), Spanish society of applied chronobiology, chronotherapy, and vascular risk (SECAC), Spanish society of aAtherosclerosis (SEA), and Romanian Society of internal medicine (RSIM). Chronobiol Int. 30:355–410. doi:10.3109/07420528.2013.750490.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Balan H, Castriotta RJ, Crespo JJ, Dagan Y, El-Toukhy S, Fernández JR, FitzGerald GA, Fujimura A, et al. 2021f. Guidelines for the design and conduct of human clinical trials on ingestion-time differences – chronopharmacology and chronotherapy – of hypertension medications. Chronobiol Int. 38:1–26. doi:10.1080/07420528.2020.1850468.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Mojón A, Crespo JJ, Ríos MT, Domínguez-Sardiña M, Otero A, Fernández JR. 2020d. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension. Expert Opin Pharmacother. 21:1167–1178. doi:10.1080/14656566.2020.1746274.
   PubMed Web of Science ®Google Scholar
• Ho CLB, Reid CM. 2022. Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease. Explor Med. 2:461–467. doi:10.37349/emed.2022.00107.
   Google Scholar
• Hounkpatin HO, Harris S, Fraser SDS, Day J, Mindell JS, Taal MW, O´donoghue D, Roderick PJ. 2020. Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016. BMJ Open. 10:e038423. doi:10.1136/bmjopen-2020-038423.
   PubMed Web of Science ®Google Scholar
• Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, Abe H, Katsuya T, Fujita Y, Okazaki O, et al. 2020. Nighttime blood pressure phenotype and cardiovascular prognosis. Practicioner-based nationwide JAMP study. Circulation. 142:1810–1820. doi:10.1161/CIRCULATIONAHA.120.049730.
   PubMed Web of Science ®Google Scholar
• Mackenzie IS, Rogers A, Poulter NR, Williams B, Brown MJ, Webb DJ, Ford I, Rorie DA, Guthrie G, Grieve JWK, et al. 2022. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomized, open-label, blinded-endpoint clinical trial. Lancet. 400:1417–1425. doi:10.1016/S0140-6736(22)01786-X.
   PubMed Web of Science ®Google Scholar
• Maqsood MH, Messerli FH, Skolnick AH, Newman JD, Berger JS, Bangalore S. 2023. Timing of antihypertensive drug therapy: a systematic review and meta-analysis of randomized clinical trials. Hypertension. 80:1544–1554. doi:10.1161/HYPERTENSIONAHA.122.20862.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, et al. 2011. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 171:1090–1098. doi:10.1001/archinternmed.2011.230.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 20:2183–2189. doi:10.1097/00004872-200211000-00017.
   PubMed Web of Science ®Google Scholar
• Poulter NR, Savoloulos C, Anjum A, Apostolopoulou M, Chapman N, Cross M, Falaschetti E, Fotiadis S, James RM, Kanellos I, et al. 2018. Randomized crossover trial of the impact of morning or evening dosing of antihypertensive agents on 24-hour ambulatory blood pressure – the HARMONY trial. Hypertension. 72:870–873. doi:10.1161/HYPERTENSIONAHA.118.11101.
   PubMed Web of Science ®Google Scholar
• Reinberg A. 1983. Clinical chronobiology. An experimental basis for chronopharmacology. In: Biological rhythms. Cellular, metabolic, pathophysiologic and pharmacologic aspects. New York: Spinger-Verlag. p. 211–263. doi:10.1007/978-1-4613-9496-96.
   Google Scholar
• Rorie DA, Flynn RWV, Mackenzie IS, MacDonald TM, Rogers A. 2017. The treatment in morning versus evening (TIME) study: analysis of recruitment, follow-up and retention rates port-recruitment. Trials. 18:557. doi:10.1186/s13063-017-2318-4.
   PubMed Web of Science ®Google Scholar
• Rorie DA, Rogers A, Mackenzie IS, Ford I, Webb DJ, Williams B, Brown M, Poulter N, Findlay E, Saywood W, et al. 2016. Methods of a large prospective, randomized, open-label, blinded end-point study comparing doses in hypertensive patients: The treatment in morning versus evening (TIME) study. BMJ Open. 6:e010313. doi:10.1136/bmjopen-2015-010313.
   PubMed Web of Science ®Google Scholar
• Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2014. Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13 844 patients with hypertension. J Hypertens. 32:2332–2340. doi:10.1097/HJH.0000000000000355.
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, Cardoso C, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700. doi:10.1161/HYPERTENSIONAHA.115.06981.
   PubMed Web of Science ®Google Scholar
• Staplin N, de la Sierra A, Ruilope LM, Emberson JR, Vinyoles E, Gorostidi M, Ruiz-Hurtado G, Segura J, Baigent C, Williams B. 2023. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59124 patients. Lancet. 401:2041–2050. doi:10.1016/So140-6736(23)00733-X.
   PubMed Web of Science ®Google Scholar
• Stergiou G, Brunström M, MacDonald T, Kyriakoulis KG, Bursztyn M, Khan N, Bakris G, Kollias A, Menti A, Muntner P, et al. 2022. Bedtime dosing of antihypertensive medications: Systematic review and consensus statement: international Society of hypertension position paper endorsed by world hypertension league and European Society of hypertension. J Hypertens. 40:1847–1858. doi:10.1097/HJH.0000000000003240.
   PubMed Web of Science ®Google Scholar
• Tapela N, Collister J, Clifton L, Turnbull I, Rahimi K, Hunter DJ. 2021. Prevalence and determinants of hypertension control among almost 100,000 treated adults in the UK. Open Heart. 8:e001461. doi:10.1136/openhrt-2020-001461.
   PubMed Web of Science ®Google Scholar
• Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F. 1998. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care. 21:597–603. doi:10.2337/diacare.21.4.597.
   PubMed Web of Science ®Google Scholar
• Umeda T, Naomi S, Iwaoka T, Inoue J, Sasaki M, Ideguchi Y, Sato T. 1994. Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension. 23:I211–I214. doi:10.1161/01.HYP.23.1_suppl.i211. PMID: 8282361.
   PubMed Web of Science ®Google Scholar
• Vickneson K, Rogers A, Anbarasan T, Rorie DA, MacDonald TM, Mackenzie IS. 2022. Factors influencing participation and long-term commitment to self-monitoring of blood pressure in a large remote clinical trial: the treatment in morning versus evening (TIME) study. J Hum Hypertens. 36:1099–1105. doi:10.1038/s41371-021-00621-5.
   PubMed Web of Science ®Google Scholar
• White WB, Black HR, Weber MA, Elliott WJ, Brysinski B, Fakourhi TD. 1998. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate–blood pressure product. Am J Cardiol. 81:424–431. doi:10.1016/s0002-9149(97)00935-1.
   PubMed Web of Science ®Google Scholar